PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia, Prostate and Breast Cancers from National Cancer Institute
Go back to PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia, Prostate and Breast Cancers from National Cancer Institute| (NASDAQ: PDSB) | Delayed: 0.81 -0.03 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $ | |||
| Open | $0.82 | 52 Week Low | $ | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $ | |||
| Volume | 18,958,144 | |||||
